MARLINA - T2D : Efficacy, Safety & Modification of Albuminuria in Type 2 Diabetes Subjects With Renal Disease With LINAgliptin
This study has been completed.
First Posted: February 15, 2013
Last Update Posted: March 6, 2017
Eli Lilly and Company
Information provided by (Responsible Party):